BIO, Making the impossible possible.
John F. Crowley

Industry leader and globally recognized patient advocate John F. Crowley
appointed to lead BIO as President & CEO

John Crowley of BIO
Become an Advocate for Biotechnology
Join BIOAction
Join BIOAction

Become an advocate for biotechnology and help shape policy that promotes innovation! Contact policymakers directly through BIO’s easy-to-use tool and have your voice heard.

Attend Our Upcoming Events
BIO  CEO & Investor Conference, CEO means opportunity, Febuary 26-27, 2024, New York

February 26-27, 2024
New York, NY

BIO International Convention. Where Business & Breakthroughs Converge. June 3-6, 2024. San Diego, CA

June 3-6, 2024
San Diego, CA

Placeholder Image

October 15-16, 2024
San Francisco, CA

What's New at BIO
BIO Early-Stage Resources Hub

BIO Early-Stage Resources Hub

BIO launched a powerful tool with exclusive resources to help early-stage and startup biotechs save money and stay up to date on the latest insights. 

BIO Webinars

BIO Webinars

BIO’s free educational webinars cover topics ranging from policy to capital raising to member services—anywhere, anytime from your own device.

Price controls on the U.S. Biopharma Ecosystem

Price controls on the U.S. Biopharma Ecosystem

New research by Vital Transformation: Inflation Reduction Act hampers R&D across therapeutic areas.

Nature's Building Blocks

Nature's Building Blocks

Explore inspiring videos about how biotech is solving our world’s biggest sustainability, health, and equity challenges, produced in partnership with BBC StoryWorks. 

The Biotechnology Economic Impact Map

The Biotechnology Economic Impact Map

Biotech’s Economic Impact. Go inside the BIO member companies driving the bioeconomy nationwide.

Why Join BIO?
David Kettner, President & General Counsel, Virent Inc

BIO’s strategic advocacy and unwavering leadership in the areas of renewable fuels and industrial products are helping to shape and drive the conversation in Washington and in state capitals across the nation.

– David Kettner, President & General Counsel, Virent, Inc.
Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals Johnson & Johnson

We are proud to work with BIO to foster transformational medical innovation to improve the health of all those living with devastating diseases around the world.

– Jennifer Taubert, EVP, Worldwide Chairman, Pharmaceuticals, J&J
Paul Hastings, PRESIDENT & CHIEF EXECUTIVE OFFICER, Nkarta

If you're an Early-Stage company like we are at Nkarta my dues get paid for by the BIO Business Solution savings...to me, it's a very easy decision to be a part of BIO.

– Paul Hastings, President & CEO, Nkarta, Inc.
Dr. Jennifer Holmgren, CEO, LanzaTech

BIO’s committees have given us a chance to be involved with other leaders on the cutting edge of biotech. We share a common goal to advance science and technology in the bioeconomy.

–Dr. Jennifer Holmgren, CEO, LanzaTech
Latest from the I am BIO Podcast
Desperate to Stop a Resistant Bacterial Infection
Desperate to Stop a Resistant Bacterial Infection
Episode 91: The Synbio Revolution is Here
The Synbio Revolution is Here
How Biotechs Survive the Valley of Death
How Biotechs Survive the Valley of Death
Subscribe to the Free Good Day BIO Newsletter
Subscribe to the Free Good Day BIO Newsletter

Over 40K subscribers worldwide can’t be wrong. Good Day BIO is the top resource for biotech industry news—and the only daily newsletter at the intersection of biotech, politics, and policy. (And, it’s free!) 

Good Day BIO Newsletter: The Latest Biotech News in 5 Minutes or Less